Virus News and Research

Latest Virus News and Research

Study shows promising basis for development of effective liver-cancer screening test

Liver cancer is the fifth most common cancer in the world and one of the deadliest cancers since it is rarely diagnosed until late in its development.

12 Apr 2010

Replikin Counts of H5N1 and H1N1 strains on the rise

The most recent BioRadar analysis of the virus genomes of both H5N1, known for high lethality, and H1N1, known for high infectivity, indicates that the Replikin Counts of both strains are rising. Such Count increases in a specific strain have been invariably associated with clinical outbreaks of that strain.

12 Apr 2010

RNAO announces winners of 2010 Awards for Excellence in Health-Care Reporting

The Registered Nurses' Association of Ontario is pleased to announce the recipients of this year's Awards for Excellence in Health-Care Reporting.

9 Apr 2010

Inovio Biomedical receives $2.8M grant to develop DNA vaccine for HCV

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that the company and its collaborators from Drexel University, Cheyney University, and the University of Pennsylvania have received a $2.8 million grant to develop a DNA vaccine to treat hepatitis C virus.

9 Apr 2010

Study finds link between autism and social influence

Social influence plays a substantial role in the surging number of autism diagnoses, according to a study published in the American Journal of Sociology.

9 Apr 2010

IFN therapy for chronic hepatitis C must be individualized and optimized for efficacy

The efficacy of interferon (IFN) therapy depends on the hepatitis C virus (HCV) genotype, pretreatment viral load and early viral kinetics. Thus, IFN therapy must be individualized and optimized according to the virological and clinical status of each patient.

9 Apr 2010

Immune system mouse models help study biology of T cells and their role in toxoplasmosis

Using T cells primed for the infectious disease toxoplasmosis, Whitehead Institute researchers have created novel mouse models of the immune system that more accurately reflect how immune cells actually respond to pathogens in their presence.

9 Apr 2010

Combination telaprevir treatment beneficial for retreatment of hepatitis C

A study co-authored by a Saint Louis University researcher found telaprevir, a protease inhibitor, combined with standard hepatitis C treatment, cures a significantly higher number of difficult-to-treat patients than standard treatment alone. The findings were published in the April issue of the New England Journal of Medicine.

9 Apr 2010

Opinions: Preparing for next flu outbreak; Elections in Zimbabwe; U.S. response to Haiti

Now that concerns about swine flu have eased, "[o]ur fear is that the public and officials will get blase about the next flu outbreak," according to a New York Times editorial. "Efforts to rush vaccine into production did not go well. This dry run should lead health officials to push the vaccine makers even harder to adopt new technologies that can turn out vaccine more quickly.

9 Apr 2010

University of Southampton, Synairgen Research scientists commence Phase II trial of interferon beta for asthma

Scientists from the University of Southampton and Synairgen Research Ltd, a respiratory drug development company spun out from the University, have begun a Phase II study into the effectiveness of the drug interferon beta for asthma patients.

9 Apr 2010

12 infected with Hepatitis C by a doctor at clinic in Victoria

Hepatitis C is a vial infection that is spread much like HIV with shared needles, blood or body fluids. The Victorian Police has been brought in to investigate a cluster of 12 hepatitis C positive cases who attended a late-term abortion clinic in Melbourne.

9 Apr 2010

Cubist Pharmaceuticals initiates dosing in Phase 2 trial with CB-183,315 for diarrhea due to CDAD

Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment and dosing of the first subject in its Phase 2 trial with CB-183,315, an antibacterial drug candidate intended to treat patients with a severe and sometimes life-threatening diarrhea caused by Clostridium difficile known as C. difficile-associated diarrhea, or CDAD. The trial is expected to enroll more than 200 subjects at 28 sites in the United States and Canada.

8 Apr 2010

Phase 1 SAD study of PSI-938 for HCV initiated

Pharmasset, Inc. announced today that dosing has initiated in a phase 1, single ascending dose study in healthy volunteers with PSI-938, a third generation purine nucleotide analog polymerase inhibitor of hepatitis C virus. Pharmasset recently filed an Investigational New Drug Application with the Food and Drug Administration.

8 Apr 2010

Telaprevir-based regimens increase rates of SVR in patients with genotype 1 HCV infection

In a clinical trial known as PROVE 3 published in this week's New England Journal of Medicine, treatment with telaprevir-based regimens significantly increased rates of sustained viral response (SVR) in patients with genotype 1 hepatitis C virus (HCV) infection who did not achieve SVR with at least one prior course of pegylated-interferon and ribavirin therapy.

8 Apr 2010

Smoking may increase risk of MS in people who have established risk factors for MS

A new study shows that smoking may increase the risk of multiple sclerosis in people who also have specific established risk factors for MS. The research is found in the April 7, 2010, online issue of Neurology, the medical journal of the American Academy of Neurology.

8 Apr 2010

USPTO allows Alnylam Pharmaceuticals' new claims from Woppmann et al. patent series

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent Office (USPTO) has allowed a patent (Application No. 10/560,336) for the Woppmann et al. patent series, entitled "Double-stranded ribonucleic acid with increased effectiveness in an organism." The newly allowed patent includes 31 claims broadly covering compositions and methods, including pharmaceutical compositions, for small interfering RNAs (siRNAs), the molecules that mediate RNAi.

8 Apr 2010

Virus News and Research

Latest Virus News and Research

Study shows promising basis for development of effective liver-cancer screening test

Replikin Counts of H5N1 and H1N1 strains on the rise

RNAO announces winners of 2010 Awards for Excellence in Health-Care Reporting

Inovio Biomedical receives $2.8M grant to develop DNA vaccine for HCV

Study finds link between autism and social influence

IFN therapy for chronic hepatitis C must be individualized and optimized for efficacy

Immune system mouse models help study biology of T cells and their role in toxoplasmosis

Combination telaprevir treatment beneficial for retreatment of hepatitis C

Opinions: Preparing for next flu outbreak; Elections in Zimbabwe; U.S. response to Haiti

University of Southampton, Synairgen Research scientists commence Phase II trial of interferon beta for asthma

12 infected with Hepatitis C by a doctor at clinic in Victoria

Cubist Pharmaceuticals initiates dosing in Phase 2 trial with CB-183,315 for diarrhea due to CDAD

Phase 1 SAD study of PSI-938 for HCV initiated

Telaprevir-based regimens increase rates of SVR in patients with genotype 1 HCV infection

Smoking may increase risk of MS in people who have established risk factors for MS

USPTO allows Alnylam Pharmaceuticals' new claims from Woppmann et al. patent series

Secretary of Health announces five health research grants to improve health of Pennsylvanians

Hepatitis C infection increases risk for developing kidney cancer

StockPreacher.com: GenVec's revenues for 2009 decline by 8%

Antigens of both influenza B virus strains can improve influenza vaccines

A new way of characterising biomolecules eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in